Stocks
Amgen Inc.AMGN
NASDAQHealthcareBiotechnology$366.21-0.43%
A major biotechnology drugmaker focused on developing and manufacturing biologic therapies for serious illnesses including cancer, cardiovascular disease, and autoimmune disorders. Its portfolio includes established blockbusters such as Enbrel, Prolia, and Otezla alongside a growing biosimilars busi...
Market Cap: $197.4B52W Range: $261.43 – $391.29
Congressional Interest in Amgen Inc. (AMGN)
18 members of Congress have disclosed 50 trades in Amgen Inc. (AMGN), a Healthcare company. The buy/sell breakdown shows 24 purchases versus 26 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
18
Buys
24
Sells
26
Who in Congress Is Trading AMGN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-03-09 | John F Reed | sell | $1K – $15K |
| 2018-02-07 | MICHAEL T. MCCAUL | sell | $15K – $50K |